Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank57
3Y CAGR-10.5%
5Y CAGR+5.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-10.5%/yr
vs +33.5%/yr prior
5Y CAGR
+5.6%/yr
Recent deceleration
Acceleration
-44.0pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $25.11M | +24.4% |
| 2024 | $20.19M | -21.0% |
| 2023 | $25.57M | -27.1% |
| 2022 | $35.05M | +9.3% |
| 2021 | $32.08M | +67.7% |
| 2020 | $19.12M | -0.6% |
| 2019 | $19.23M | +74.1% |
| 2018 | $11.05M | - |